Form 4: QuidelOrtho Chief Legal Officer Reports Stock Transactions

QuidelOrtho's Chief Legal Officer, Michelle A. Hodges, reported the vesting of restricted stock units and subsequent share disposition for tax obligations.

Summary

• Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp (QDEL), reported transactions involving the company's common stock.
• On November 18, 2025, 5,349 shares of common stock were acquired due to the release of previously reported restricted stock units (RSUs).
• Concurrently, 2,717 shares of common stock were disposed of at a price of $21.28 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Michelle A. Hodges beneficially owns 32,035 shares of common stock directly.
• An additional 10,698 restricted stock units remain, with vesting scheduled in equal installments on November 18, 2026, and November 18, 2027.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation, which are neutral in sentiment as they reflect standard operational procedures rather than new performance insights or strategic shifts.

Positives

• The vesting of 5,349 restricted stock units represents a realization of executive compensation for Michelle A. Hodges.

Negatives

• The disposition of 2,717 shares for tax withholding purposes reduces the direct beneficial ownership of common stock.

Future Outlook

The filing indicates future vesting events for remaining restricted stock units on November 18, 2026, and November 18, 2027, which will result in additional common stock acquisitions for the reporting person.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities. Such transactions are common across publicly traded companies as part of their executive compensation programs.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine compensation-related transaction by an executive, not indicative of a change in company fundamentals or strategy.
• Employees: No direct impact on the broader employee base is indicated by this filing.

Next Steps

• Future vesting of 10,698 restricted stock units in equal installments on November 18, 2026, and November 18, 2027.

Key Dates

Keywords

QuidelOrtho, QDEL, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Stock Vesting, Tax Withholding